CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...
Phase 1, Phase 2
Orlando, Florida, United States and 53 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
Lake Mary, Florida, United States and 22 other locations
Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...
Phase 3
Orlando, Florida, United States and 51 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Orlando, Florida, United States and 388 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Orange City, Florida, United States and 249 other locations
activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regi...
Phase 1
Orlando, Florida, United States and 7 other locations
be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to t...
Phase 2
Orlando, Florida, United States and 50 other locations
prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...
Phase 3
Orlando, Florida, United States and 538 other locations
Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...
Phase 3
Clermont, Florida, United States and 258 other locations
The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned t...
Phase 3
Orlando, Florida, United States and 559 other locations
Clinical trials
Research sites
Resources
Legal